• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Investigation Genetic variation of Neuraminidase gene in Influenza virus A H1N1/pdm09, Shiraz, Iran (2015-2016)

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Feb 19.
doi: 10.1002/jmv.26894. Online ahead of print.
Investigation Genetic variation of Neuraminidase gene in Influenza virus A H1N1/pdm09, Shiraz, Iran (2015-2016)


Omid Rashidi[SUP] 1 [/SUP], Afagh Moattari[SUP] 2 [/SUP], Neda Pirbonyeh[SUP] 1 3 [/SUP], Amir Emami[SUP] 4 [/SUP], Mohammad Rahim Kadivar[SUP] 5 [/SUP], Nahid Tavakoli Movaghar[SUP] 1 [/SUP], Fahimeh Edalat[SUP] 1 [/SUP]



Affiliations

Abstract

Oseltamivir and antiviral agents are frequently used for the prevention and treatment of influenza infection. However, resistance to oseltamivir has been reported globally due to a mutation in the Influenza virus neuraminidase gene. Such resistance will be detected by genotyping and phenotyping studies of viral isolates. The recent study aimed to determine the genetic mutation of neuraminidase gene in Influenza A (H1N1) viruses isolated from children referred to Shiraz tertiary hospitals during one year (2015-2016) with influenza-like symptoms. A total of 300 patients were registered and throat samples were taken. The throat swabs were used for viral RNA extraction. Detection of Influenza A (H1N1) was performed using the one-step real-time polymerase chain reaction (qRT-PCR) method. From positive isolates for H1N1, 51 random samples were evaluated for neuraminidase gene mutation with the nested PCR-sequencing method. Of 300 cases, 102(34%) isolates were detected as influenza A(H1N1) pdm09. Based on sequencing results, 2 of 44 sequenced isolates exhibited H275Y substitution, which presented oseltamivir resistance. In comparison with reference strain, the phylogenetic analysis of sequenced isolates was classified in genogroup 6B. While this result is the first report of emerging oseltamivir-resistant in the southwest of Iran, it is highly recommended to perform these evaluations on the different geographical regions in any prevalence area to plan treatment strategies for Influenza. This article is protected by copyright. All rights reserved.

Keywords: H1N1; influenza A virus; mutation; oseltamivir-resistant.
 
Back
Top Bottom